KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Inventory: 2016-2025

Historic Inventory for Acadia Pharmaceuticals (ACAD) over the last 10 years, with Sep 2025 value amounting to $29.1 million.

  • Acadia Pharmaceuticals' Inventory fell 52.33% to $29.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.1 million, marking a year-over-year decrease of 52.33%. This contributed to the annual value of $21.9 million for FY2024, which is 38.72% down from last year.
  • Per Acadia Pharmaceuticals' latest filing, its Inventory stood at $29.1 million for Q3 2025, which was up 11.38% from $26.1 million recorded in Q2 2025.
  • In the past 5 years, Acadia Pharmaceuticals' Inventory registered a high of $71.5 million during Q2 2024, and its lowest value of $5.8 million during Q3 2022.
  • Moreover, its 3-year median value for Inventory was $26.1 million (2025), whereas its average is $33.3 million.
  • In the last 5 years, Acadia Pharmaceuticals' Inventory surged by 916.18% in 2024 and then plummeted by 63.48% in 2025.
  • Over the past 5 years, Acadia Pharmaceuticals' Inventory (Quarterly) stood at $7.9 million in 2021, then decreased by 15.80% to $6.6 million in 2022, then skyrocketed by 439.77% to $35.8 million in 2023, then tumbled by 38.72% to $21.9 million in 2024, then plummeted by 52.33% to $29.1 million in 2025.
  • Its Inventory stands at $29.1 million for Q3 2025, versus $26.1 million for Q2 2025 and $22.9 million for Q1 2025.